Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page